• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Chief Executive Officer Bhojwani Gary C sold $2,211,674 worth of Common Stock (53,912 units at $41.02), decreasing direct ownership by 21% to 202,666 units (SEC Form 4)

    4/3/25 4:47:48 PM ET
    $CNO
    Accident &Health Insurance
    Finance
    Get the next $CNO alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
    X
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Bhojwani Gary C

    (Last) (First) (Middle)
    C/O CNO FINANCIAL GROUP, INC.
    11299 ILLINOIS STREET, SUITE 200

    (Street)
    CARMEL IN 46032

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    CNO Financial Group, Inc. [ CNO ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    X Officer (give title below) Other (specify below)
    Chief Executive Officer
    3. Date of Earliest Transaction (Month/Day/Year)
    04/01/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 04/01/2025 S 18,215(1) D $41.356(2) 238,363 D
    Common Stock 04/01/2025 S 20,697(1) D $41.3537(3) 217,666 D
    Common Stock 04/03/2025 S 15,000(1) D $40.1651(4) 202,666 D
    Common Stock 700,587 I Gary C. Bhojwani Revocable Trust
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. Shares sold pursuant to a Rule 10b5-1 trading plan adopted on December 11, 2024.
    2. Reflects the weighted average sale price. Shares were sold at prices ranging from $41.179 per share to $41.64 per share. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer.
    3. Reflects the weighted average sale price. Shares were sold at prices ranging from $41.185 per share to $41.64 per share. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer.
    4. Reflects the weighted average sale price. Shares were sold at prices ranging from $39.67 per share to $41.03 per share. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer.
    Remarks:
    Heidi M. Krings, Attorney-in-Fact 04/03/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $CNO alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CNO

    DatePrice TargetRatingAnalyst
    1/23/2025$38.00Market Perform
    BMO Capital Markets
    4/16/2024$29.00Neutral → Overweight
    Piper Sandler
    1/4/2024$24.00 → $26.00In-line → Underperform
    Evercore ISI
    6/29/2023Mkt Perform
    Raymond James
    9/13/2022$25.00Outperform
    RBC Capital Mkts
    1/26/2022$25.00Hold
    Jefferies
    1/7/2022$27.00 → $28.00Equal-Weight
    Morgan Stanley
    1/5/2022$29.00 → $27.00Overweight → Neutral
    Piper Sandler
    More analyst ratings

    $CNO
    SEC Filings

    See more
    • CNO Financial Group Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - CNO Financial Group, Inc. (0001224608) (Filer)

      6/10/25 7:52:21 AM ET
      $CNO
      Accident &Health Insurance
      Finance
    • SEC Form 13F-HR filed by CNO Financial Group Inc.

      13F-HR - CNO Financial Group, Inc. (0001224608) (Filer)

      5/14/25 4:45:03 PM ET
      $CNO
      Accident &Health Insurance
      Finance
    • SEC Form 10-Q filed by CNO Financial Group Inc.

      10-Q - CNO Financial Group, Inc. (0001224608) (Filer)

      5/7/25 4:21:36 PM ET
      $CNO
      Accident &Health Insurance
      Finance